EnBio Holdings, Inc (TYO:6092)
612.00
-20.00 (-3.16%)
At close: Feb 13, 2026
EnBio Holdings Balance Sheet
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Cash & Equivalents | 3,760 | 3,293 | 3,604 | 2,828 | 2,371 | 2,015 |
Cash & Short-Term Investments | 3,760 | 3,293 | 3,604 | 2,828 | 2,371 | 2,015 |
Cash Growth | 9.72% | -8.63% | 27.44% | 19.28% | 17.67% | -32.41% |
Receivables | 2,070 | 2,354 | 1,270 | 792 | 1,593 | 948 |
Inventory | 3,671 | 2,952 | 2,889 | 3,373 | 1,849 | 3,119 |
Other Current Assets | 447 | 358 | 483 | 325 | 645 | 533 |
Total Current Assets | 9,948 | 8,957 | 8,246 | 7,318 | 6,458 | 6,615 |
Property, Plant & Equipment | 9,171 | 8,827 | 7,918 | 7,016 | 7,914 | 7,332 |
Long-Term Investments | 2,692 | 1,403 | 1,375 | 1,186 | 1,221 | 1,012 |
Goodwill | 90 | 94 | 102 | 110 | 118 | 126 |
Other Intangible Assets | 341 | 351 | 373 | 399 | 427 | 454 |
Long-Term Deferred Charges | - | - | - | - | - | 2 |
Other Long-Term Assets | 2 | 2 | 1 | 1 | 2 | 2 |
Total Assets | 22,244 | 21,195 | 19,310 | 17,349 | 16,370 | 15,698 |
Accounts Payable | 1,104 | 855 | 1,098 | 485 | 693 | 595 |
Accrued Expenses | 20 | 41 | 36 | 31 | 50 | - |
Short-Term Debt | 1,352 | 1,788 | 1,088 | 854 | 645 | 955 |
Current Portion of Long-Term Debt | 1,576 | 1,666 | 1,300 | 2,293 | 1,276 | 1,050 |
Current Income Taxes Payable | 301 | 199 | 183 | 316 | 315 | 20 |
Other Current Liabilities | 469 | 269 | 439 | 492 | 467 | 408 |
Total Current Liabilities | 4,822 | 4,818 | 4,144 | 4,471 | 3,446 | 3,028 |
Long-Term Debt | 7,360 | 6,643 | 6,230 | 5,749 | 6,660 | 7,030 |
Other Long-Term Liabilities | 574 | 504 | 347 | 273 | 290 | 323 |
Total Liabilities | 12,756 | 11,965 | 10,721 | 10,493 | 10,396 | 10,381 |
Common Stock | 2,325 | 2,325 | 2,325 | 1,797 | 1,797 | 1,794 |
Additional Paid-In Capital | 2,404 | 2,404 | 2,405 | 1,876 | 1,876 | 1,873 |
Retained Earnings | 4,620 | 4,149 | 3,761 | 3,111 | 2,352 | 1,743 |
Treasury Stock | -38 | -38 | -15 | -15 | -15 | - |
Comprehensive Income & Other | 94 | 301 | 17 | 18 | -121 | -123 |
Total Common Equity | 9,405 | 9,141 | 8,493 | 6,787 | 5,889 | 5,287 |
Minority Interest | 83 | 89 | 96 | 69 | 85 | 30 |
Shareholders' Equity | 9,488 | 9,230 | 8,589 | 6,856 | 5,974 | 5,317 |
Total Liabilities & Equity | 22,244 | 21,195 | 19,310 | 17,349 | 16,370 | 15,698 |
Total Debt | 10,288 | 10,097 | 8,618 | 8,896 | 8,581 | 9,035 |
Net Cash (Debt) | -6,528 | -6,804 | -5,014 | -6,068 | -6,210 | -7,020 |
Net Cash Per Share | -806.77 | -840.11 | -628.52 | -913.63 | -934.94 | -1056.54 |
Filing Date Shares Outstanding | 8.1 | 8.1 | 8.14 | 8.14 | 6.64 | 6.59 |
Total Common Shares Outstanding | 8.1 | 8.1 | 8.14 | 6.64 | 6.64 | 6.65 |
Working Capital | 5,126 | 4,139 | 4,102 | 2,847 | 3,012 | 3,587 |
Book Value Per Share | 1161.17 | 1128.50 | 1043.71 | 1022.55 | 886.25 | 795.33 |
Tangible Book Value | 8,974 | 8,696 | 8,018 | 6,278 | 5,344 | 4,707 |
Tangible Book Value Per Share | 1107.95 | 1073.57 | 985.33 | 945.86 | 804.23 | 708.08 |
Order Backlog | - | 2,942 | 3,624 | 2,912 | 1,514 | 2,633 |
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.